Boosting the Potential of circRNA - Portal and MGB GCTI

Boosting the Potential of circRNA - Portal and MGB GCTI

Circular RNA is opening new doors for cell engineering from longer-lasting protein expression to multiplexed cargo delivery. Join researchers from MGB's Gene Therapy & Cell Innovation center and Portal Bio for a look at what makes circRNA exciting and what we're seeing as this technology moves from bench to application.

What You'll Learn:

  • Why circular RNA: what makes it distinct from linear mRNA and where the field is heading
  • Benefits of delivering multiple circRNA constructs to immune cells in a single step
  • Uses of circRNA in stem cells and other hard-to-transfect cell types
  • How multiplexed circRNA delivery enables co-expression of multiple proteins with sustained duration
  • Early results: what the data is showing for cell therapy and engineering applications
  • Armon Sharei, Ph.D.

    Founder and CEO

  • Armon Sharei, Ph.D.

    Founder and CEO